Radius Health to Present at the 35th Annual J.P. Morgan Healthcare Conference
January 06 2017 - 8:40AM
Radius Health, Inc. (Nasdaq:RDUS), a science-driven
biopharmaceutical company focused on developing innovative
therapeutics in the areas of osteoporosis, oncology and endocrine
diseases, today announced that President and Chief Executive
Officer, Robert E. Ward, will present at the 35th Annual J.P.
Morgan Healthcare Conference on Monday, January 9, 2017 at 11:00
a.m. PST at the Westin St. Francis Hotel in San Francisco,
California.
The Company's presentation will be webcast live on the Company's
website at www.radiuspharm.com, and a replay will be available
there following the presentation. The Company will also post a copy
of the presentation materials on its website,
www.radiuspharm.com.
About Radius
Radius is a science-driven biopharmaceutical company that is
committed to developing innovative therapeutics in the areas of
osteoporosis, oncology and endocrine diseases. Radius' lead product
candidate, the investigational drug abaloparatide for subcutaneous
injection, has completed Phase 3 development for potential use in
the reduction of fracture risk in postmenopausal women with
osteoporosis. Radius' Marketing Authorisation Application (MAA) for
abaloparatide-SC for the treatment of postmenopausal women with
osteoporosis is under regulatory review in Europe and a New Drug
Application (NDA) has been accepted for filing by the FDA with a
PDUFA date of March 30, 2017. The Radius clinical pipeline also
includes an investigational abaloparatide transdermal patch for
potential use in osteoporosis and the investigational drug RAD1901
for potential use in hormone-driven and/or hormone-resistant breast
cancer, and vasomotor symptoms in postmenopausal women. Radius'
preclinical pipeline includes RAD140, a non-steroidal, selective
androgen receptor modulator (SARM) under investigation for
potential use in cancer. For more information, please
visit www.radiuspharm.com
Investor Relations Contact:
Barbara Ryan
Email: bryan@radiuspharm.com
Phone: 203-274-2825
Media Contact:
Lori Gorski
Email: lgorski@radiuspharm.com
Phone: 617-551-4096
Radius Recycling (NASDAQ:RDUS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Radius Recycling (NASDAQ:RDUS)
Historical Stock Chart
From Apr 2023 to Apr 2024